Silvia Bozzarelli

Usefulness of alpha-fetoprotein response in patients treated with sorafenib for advanced hepatocellular carcinoma

Nicola Personeni, Silvia Bozzarelli, Tiziana Pressiani et al. · Journal of Hepatology · 2012 · 206 citations

Hepatology, Hepatocellular Carcinoma, Medicine +8

Phase II Study of Tivantinib and Cetuximab in Patients With KRAS Wild-type Metastatic Colorectal Cancer With Acquired Resistance to EGFR Inhibitors and Emergence of MET Overexpression: Lesson Learned for Future Trials With EGFR/MET Dual Inhibition

Lorenza Rimassa, Silvia Bozzarelli, Filippo Pietrantonio et al. · Clinical Colorectal Cancer · 2019 · 51 citations

Oncology, Acquired Resistance, Medicine +7

Estimating 12-week death probability in patients with refractory metastatic colorectal cancer: the Colon Life nomogram

Filippo Pietrantonio, Rosalba Miceli, Lorenza Rimassa et al. · Annals of Oncology · 2016 · 49 citations · Full text

Surgical Oncology, Medicine, 12-Week Death Probability +8

Molecular determinants of outcome in sorafenib-treated patients with hepatocellular carcinoma

Nicola Personeni, Lorenza Rimassa, Tiziana Pressiani et al. · Journal of Cancer Research and Clinical Oncology · 2013 · 39 citations · Full text

Hepatology, Medicine, Pathology +6

<i><scp>KRAS</scp></i> mutation in lung metastases from colorectal cancer: prognostic implications

Michele Ghidini, Nicola Personeni, Silvia Bozzarelli et al. · Cancer Medicine · 2015 · 35 citations · Full text